1.Wong, ND (2007) Metabolic syndrome – cardiovascular risk assessment and management. Am J Cardiovasc Drug 7, 259–272.
2.Grundy, SM (2008) Metabolic syndrome pandemic. Arterioscl Throm Vas 28, 629–636.10.1161/ATVBAHA.107.151092
3.Pereira, MA, Kottke, TE, Jordan, C, et al. (2009) Preventing and managing cardiometabolic risk: the logic for intervention. Int J Environ Res Public Health 6, 2568–2584.
4.Lin, DR, Xiao, MS, Zhao, JJ, et al. (2016) An overview of plant phenolic compounds and their importance in human nutrition and management of type 2 diabetes. Molecules 21, 1374–1393.
5.Amiot, MJ, Riva, C & Vinet, A (2016) Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review. Obes Rev 17, 573–586.
6.Majumder, K & Wu, JP (2015) Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension. Int J Mol Sci 16, 256–283.
7.Udenigwe, CC & Rouvinen-Watt, K (2015) The role of food peptides in lipid metabolism during dyslipidemia and associated health conditions. Int J Mol Sci 16, 9303–9313.
8.Chakrabarti, S, Jahandideh, F & Wu, JP (2014) Food-derived bioactive peptides on inflammation and oxidative stress. Biomed Res Int 2014, 1–11.
9.Morifuji, M, Koga, J, Kawanaka, K, et al. (2009) Branched-chain amino acid-containing dipeptides, identified from whey protein hydrolysates, stimulate glucose uptake rate in L6 myotubes and isolated skeletal muscles. J Nutr Sci Vitaminol 55, 81–86.
10.Tong, X, Li, W, Xu, JY, et al. (2014) Effects of whey protein and leucine supplementation on insulin resistance in non-obese insulin-resistant model rats. Nutrition 30, 1076–1080.
11.Lavigne, C, Tremblay, F, Asselin, G, et al. (2001) Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. Am J Physiol Endocrinol Metab 281, E62–E71.
12.Boonloh, K, Kukongviriyapan, V, Kongyingyoes, B, et al. (2015) Rice bran protein hydrolysates improve insulin resistance and decrease pro-inflammatory cytokine gene expression in rats fed a high carbohydrate-high fat diet. Nutrients 7, 6313–6329.
13.Tremblay, F, Lavigne, C, Jacques, H, et al. (2001) Dietary cod protein prevents obesity-linked insulin resistance by normalizing the activation of the PI 3-kinase/Akt pathway by insulin in skeletal muscle. Diabetes 50, A296–A297.
14.Lu, JL, Zeng, Y, Hou, WR, et al. (2012) The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway. J Nutr Biochem 23, 1449–1457.
15.Morato, PN, Lollo, PCB, Moura, CS, et al. (2013) Whey protein hydrolysate increases translocation of GLUT-4 to the plasma membrane independent of insulin in wistar rats. PLOS ONE 8, e71134.
16.Kwak, JH, Lee, JH, Ahn, CW, et al. (2010) Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type 2 diabetes mellitus. J Med Food 13, 1307–1312.
17.Noguchi, N, Yanagita, T, Rahman, SM, et al. (2016) Chlorella protein hydrolysate attenuates glucose metabolic disorder and fatty liver in high-fat diet-induced obese mice. J Oleo Sci 65, 613–620.
18.Aihara, K, Osaka, M & Yoshida, M (2014) Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice. Br J Nutr 112, 513–519.
19.Sawada, Y, Sakamoto, Y, Toh, M, et al. (2015) Milk-derived peptide Val-Pro-Pro (VPP) inhibits obesity-induced adipose inflammation via an angiotensin-converting enzyme (ACE) dependent cascade. Mol Nutr Food Res 59, 2502–2510.
20.Jahandideh, F, Chakrabarti, S, Davidge, ST, et al. (2017) Egg white hydrolysate shows insulin mimetic and sensitizing effects in 3T3-F442A pre-adipocytes. PLOS ONE 12, e0185653.
21.Moreno-Fernandez, S, Garces-Rimon, M, Gonzalez, C, et al. (2018) Pepsin egg white hydrolysate ameliorates metabolic syndrome in high-fat/high-dextrose fed rats. Food Funct 9, 78–86.
22.Ochiai, M & Azuma, Y (2017) Egg white hydrolysate improves glucose tolerance in type-2 diabetic NSY mice. J Nutr Sci Vitaminol 63, 422–429.
23.Garces-Rimon, M, Gonzalez, C, Uranga, JA, et al. (2016) Pepsin egg white hydrolysate ameliorates obesity-related oxidative stress, inflammation and steatosis in Zucker fatty rats. PLOS ONE 11, e0151193.
24.Jahandideh, F, Chakrabarti, S, Majumder, K, et al. (2016) Egg white protein hydrolysate reduces blood pressure, improves vascular relaxation and modifies aortic angiotensin II receptors expression in spontaneously hypertensive rats. J Funct Foods 27, 667–673.
25.Marcus, Y, Shefer, G & Stern, N (2013) Adipose tissue renin–angiotensin–aldosterone system (RAAS) and progression of insulin resistance. Mol Cell Endocrinol 378, 1–14.
26.Henriksen, EJ, Jacob, S, Kinnick, TR, et al. (2001) Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 38, 884–890.
27.Olivares-Reyes, JA, Arellano-Plancarte, A & Castillo-Hernandez, JR (2009) Angiotensin II and the development of insulin resistance: implications for diabetes. Mol Cell Endocrinol 302, 128–139.
28.Underwood, PC & Adler, GK (2013) The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 15, 59–70.
29.Hashemi, Z, Yang, KY, Yang, H, et al. (2015) Cooking enhances beneficial effects of pea seed coat consumption on glucose tolerance, incretin, and pancreatic hormones in high-fat-diet-fed rats. Appl Physiol Nutr Metab 40, 323–333.
30.Steinberg, GR & Kemp, BE (2009) AMPK in health and disease. Physiol Rev 89, 1025–1078.
31.Olefsky, JM & Saltiel, AR (2000) PPAR gamma and the treatment of insulin resistance. Trends Endocrin Met 11, 362–368.
32.Lteif, AA, Han, K & Mather, KJ (2005) Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 112, 32–38.
33.Yang, KY, Hashemi, Z, Han, W, et al. (2015) Hydrolysis enhances bioavailability of proanthocyanidin-derived metabolites and improves β-cell function in glucose intolerant rats. J Nutr Biochem 26, 850–859.
34.Cerf, ME, Chapman, CS & Louw, J (2012) High-fat programming of hyperglycemia, hyperinsulinemia, insulin resistance, hyperleptinemia, and altered islet architecture in 3-month-old wistar rats. ISRN Endocrinol 2012, 627270.
35.Shihabudeen, MS, Roy, D, James, J, et al. (2015) Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance. Mol Cell Endocrinol 414, 19–28.
36.Johnson, JA, Trasino, SE, Ferrante, AW, et al. (2007) Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats. Obesity 15, 2653–2663.
37.Jung, UJ, Cho, YY & Choi, MS (2016) Apigenin ameliorates dyslipidemia, hepatic steatosis and insulin resistance by modulating metabolic and transcriptional profiles in the liver of high-fat diet-induced obese mice. Nutrients 8, 305.
38.Shih, CC, Shlau, MT, Lin, CH, et al. (2014) Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and ampk phosphorylation in high-fat-fed mice. Phytother Res 28, 363–371.
39.de Campos Zani, SC, Wu, J & Chan, BC (2018) Egg and soy-derived peptides and hydrolysates: a review of their physiological actions against diabetes and obesity. Nutrients 10, 549.
40.Horton, JD, Goldstein, JL & Brown, MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109, 1125–1131.
41.Goossens, GH (2008) The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94, 206–218.
42.Jahandideh, F, Liu, P & Wu, J (2018) Purification and identification of adipogenic-differentiating peptides from egg white hydrolysate. Food Chem 259, 25–30.
43.Kubota, N, Terauchi, Y, Kubota, T, et al. (2006) Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281, 8748–8755.
44.Hallakou, S, Doare, L, Foufelle, F, et al. (1997) Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46, 1393–1399.
45.Neels, JG & Olefsky, JM (2006) Inflamed fat: what starts the fire? J Clin Invest 116, 33–35.
46.de Luca, C & Olefsky, JM (2008) Inflammation and insulin resistance. FEBS Lett 582, 97–105.
47.Kassi, E, Pervanidou, P, Kaltsas, G, et al. (2011) Metabolic syndrome: definitions and controversies. BMC Med 9, 48.
48.Paul, M, Poyan Mehr, A & Kreutz, R (2006) Physiology of local renin–angiotensin systems. Physiol Rev 86, 747–803.
49.Chu, KY & Leung, PS (2009) Angiotensin II in type 2 diabetes mellitus. Curr Protein Pept Sci 10, 75–84.
50.Dietze, GJ & Henriksen, EJ (2008) Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis. J Renin-Angiotensin-Aldosterone Syst JRAAS 9, 75–88.
51.Lastra, G, Habibi, J, Whaley-Connell, AT, et al. (2009) Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression. Endocrinology 150, 2561–2568.
52.Marchionne, EM, Diamond-Stanic, MK, Prasonnarong, M, et al. (2012) Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 302, R137–R142.
53.Goossens, GH, Moors, CC, van der Zijl, NJ, et al. (2012) Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial. PLOS ONE 7, e39930.
54.Lender, D, Arauz-Pacheco, C, Breen, L, et al. (1999) A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 12, 298–303.
55.Chai, WD, Wang, WH, Dong, ZH, et al. (2011) Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes 60, 2939–2946.
56.Henriksen, EJ (2007) Improvement of insulin sensitivity by antagonism of the renin–angiotensin system. Am J Physiol Regul Integr Comp Physiol 293, R974–R980.
57.Majumder, K, Chakrabarti, S, Morton, JS, et al. (2013) Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats. PLOS ONE 8, e82829.
58.Son, M, Chan, CB & Wu, J (2018) Egg white ovotransferrin-derived ACE inhibitory peptide ameliorates angiotensin II-stimulated insulin resistance in skeletal muscle cells. Mol Nutr Food Res 62, 1700602.
59.Yvan-Charvet, L, Even, P, Bloch-Faure, M, et al. (2005) Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54, 991–999.
60.Shum, M, Pinard, S, Guimond, MO, et al. (2013) Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. Am J Physiol Endocrinol Metab 304, E197–E210.